Location, Location, Location: Will Sorrento’s China-Only NSCLC Data Fly With US FDA?

 
• By Alaric DeArment

Sorrento plans to meet with the US FDA regarding abivertinib, but the agency’s tough stance on drug approvals based on single-country studies could thwart the company’s efforts.

Sorrento's intention to go to the FDA raise the question of how the agency will view its China-only data • Source: Shutterstock

More from US FDA

More from Agency Leadership